Literature DB >> 28278578

Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.

Navid Ahmadi Nasab1, Hassan Hassani Kumleh2, Mojtaba Beygzadeh3, Shahram Teimourian4, Mahmood Kazemzad3.   

Abstract

Mesoporous silica nanocarriers as accommodate drug molecule capsules were synthesized and capped by chitosan natural polymer. This nanocarrier acts as a pH-responsive shield to increase the solubility and improvement of anticancer properties of curcumin against U87MG glioblastoma cancer cell line. The encapsulation efficiency and drug-loading content were measured 88.1 ± 4.76% and 8.81 ± 0.47%, respectively. The curcumin release from the CS-MCM-41 was slow and sustained at low pH (42.72 ± 2.29%) compared to the environment pH (19.54 ± 1.36%) in 96 h. The MTT evaluations showed that IC50 after 72 h treatment with free curcumin and curcumin-loaded CS-MCM-41 were 15.20 and 5.21 μg/mL (p <0.05). respectively.

Entities:  

Keywords:  Mesoporous silica; cancer therapy; chitosan; drug delivery; nanomedicine; pH sensitive

Mesh:

Substances:

Year:  2017        PMID: 28278578     DOI: 10.1080/21691401.2017.1290648

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  17 in total

1.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

Review 2.  Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances.

Authors:  Reema Narayan; Usha Y Nayak; Ashok M Raichur; Sanjay Garg
Journal:  Pharmaceutics       Date:  2018-08-06       Impact factor: 6.321

Review 3.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 4.  Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications.

Authors:  Yan Chen; Yao Lu; Robert J Lee; Guangya Xiang
Journal:  Int J Nanomedicine       Date:  2020-05-01

Review 5.  Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases.

Authors:  Bahare Salehi; Daniela Calina; Anca Oana Docea; Niranjan Koirala; Sushant Aryal; Domenico Lombardo; Luigi Pasqua; Yasaman Taheri; Carla Marina Salgado Castillo; Miquel Martorell; Natália Martins; Marcello Iriti; Hafiz Ansar Rasul Suleria; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

6.  Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin.

Authors:  Ahmed M Omer; Zyta M Ziora; Tamer M Tamer; Randa E Khalifa; Mohamed A Hassan; Mohamed S Mohy-Eldin; Mark A T Blaskovich
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

Review 7.  Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.

Authors:  Khaled AbouAitah; Witold Lojkowski
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

Review 8.  Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.

Authors:  L Nam; C Coll; L C S Erthal; C de la Torre; D Serrano; R Martínez-Máñez; M J Santos-Martínez; E Ruiz-Hernández
Journal:  Materials (Basel)       Date:  2018-05-11       Impact factor: 3.623

9.  pH-Triggered Drug Release Controlled by Poly(Styrene Sulfonate) Growth Hollow Mesoporous Silica Nanoparticles.

Authors:  Fajar R Wibowo; Ozi A Saputra; Witri W Lestari; Mamoru Koketsu; Rino R Mukti; Ronny Martien
Journal:  ACS Omega       Date:  2020-02-20

Review 10.  Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review.

Authors:  Mahshid Moballegh Nasery; Banafshe Abadi; Delaram Poormoghadam; Ali Zarrabi; Peyman Keyhanvar; Hashem Khanbabaei; Milad Ashrafizadeh; Reza Mohammadinejad; Shima Tavakol; Gautam Sethi
Journal:  Molecules       Date:  2020-02-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.